Arthur J. Gallagher & Co. reports Q1 2026 results tonight, and the most interesting tension isn't in the options market — it's in the unusual short interest reversal that landed just days before the print.
The clearest positioning story this week is the sharp drop in short interest. Estimated SI fell 15% over the past seven days to 2.4% of the free float — one of the more dramatic single-week pullbacks in the past six weeks. Shorts had been building steadily through mid-April, climbing from roughly 5.0m shares in early March to a peak above 7.5m by April 17. Then the reversal: in just two sessions around April 23-24, nearly 1.4m shares of short interest evaporated. That retreat brought SI back to where it was in early April, erasing the bulk of the build. The monthly picture still shows a 25% net increase, a reminder that the overall bias through April was more bearish than the week's close suggests. Availability in the lending market remains generous — borrow costs are just 0.48% and availability is loose, so there is no mechanical squeeze driving the cover. Shorts appear to be choosing to exit ahead of the earnings event rather than being forced out. Options positioning backs that read: the put/call ratio is running at 0.45, marginally below its 20-day average of 0.47 and well off the 52-week high of 0.94, with a z-score of -0.68. Demand for downside protection is actually below normal.
The Street remains broadly constructive, though less so than a month ago. The mean price target among analysts is $271, implying roughly 26% upside to the current $211.81 close — a gap that reflects how far the stock has pulled back. AJG is down about 17% year-to-date, and that drawdown has pulled multiple analysts into target-trimming mode. Mizuho and Wells Fargo both clipped targets in early April while holding Outperform and Overweight ratings respectively; Barclays bucked the trend by lifting its target to $275. The overall direction of the recent changes is lower targets with unchanged bullish ratings — a pattern that says analysts still believe in the name but are acknowledging that the macro environment has changed. Keefe, Bruyette & Woods holds the most cautious published stance at Market Perform with a $246 target. BMO upgraded to Outperform in late March. The 12-month forward EPS growth ranking lands in the 95th percentile, which helps explain why the bulls aren't walking away — forward earnings expectations remain robust even as the stock price has lagged.
One place where the data tells a more complicated story is valuation. The trailing P/E has drifted down to 15.5x, contracting by about 0.6x over the past week alone. The EV/EBITDA multiple has also compressed by roughly 0.2x over the same period. For a business with the earnings growth profile the Street is pricing in, these multiples are not stretched — but the EV/EBIT factor score ranks in just the 10th percentile, a signal that on an absolute earnings-power basis the valuation still carries a premium versus the broader universe. The EPS surprise rank at the 15th percentile is notable in context: AJG has not been a consistent beats-and-raises story recently, which may partially explain why the stock has underperformed the analyst community's optimism.
Institutional ownership is deeply conventional. Vanguard, Capital Research, and BlackRock together hold more than 27% of shares. T. Rowe Price added 3.4 million shares in the most recent reported quarter — a meaningful build for a name of this size — while FMR (Fidelity) added 2.3 million. Insider activity at the March 31 quarter-end was dominated by routine award-and-sell transactions at near-zero significance scores; nothing in the recent insider record points to unusual conviction in either direction.
Among close peers, BRO had a worse week — down over 8% — while AON lost about 4%. WTW fared best of the majors, off just 2.3%. AJG's 4.2% weekly decline sits in the middle of the peer range, suggesting the sector as a whole absorbed pressure this week rather than AJG-specific selling. The outlier is GSHD, which rallied nearly 10% on the week, though its business profile is quite different. Tonight's print — and specifically whether AJG can validate the forward EPS trajectory analysts are counting on — is the data point the rest of April's positioning has been building toward.
See the live data behind this article on ORTEX.
Open AJG on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
